They are prescription-only medicines (POMs) subject to rigorous regulatory oversight, with clear indications, dosing schedules, and safety monitoring requirements
During the initial phase of treatment for pernicious anemia, serum potassium levels should be monitored to prevent hypokalemia and cardiac arrest
over time, seasons of rain and years of drought
Treatment time-courses reveal sequential activation patterns, with initial VEGFR2 phosphorylation preceding downstream FAK and paxillin activation
Proper injection technique minimizes these effects
For example: Two human trials one in 2006, the other in 2013 found that even very small weekly doses (30-90mcg) of CJC-1295 resulted in increased [minimum] and mean [growth hormone] secretion and